Literature DB >> 14500502

Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria.

Robert J Feezor1, Caroline Oberholzer, Henry V Baker, Daniela Novick, Menachem Rubinstein, Lyle L Moldawer, John Pribble, Sonia Souza, Charles A Dinarello, Wolfgang Ertel, Andreas Oberholzer.   

Abstract

Sepsis caused by gram-negative bacteria and that caused by gram-positive bacteria often manifest similar clinical features. We investigated plasma proinflammatory cytokine profiles in patients with sepsis due to gram-positive and gram-negative bacteria and studied the cytokine production and differential gene regulation of leukocytes stimulated ex vivo with Escherichia coli lipopolysaccharide or heat-killed Staphylococcus aureus. Concentrations of tumor necrosis factor alpha, interleukin 1 receptor antagonist (IL-1Ra), IL-8, IL-10, IL-18 binding protein, procalcitonin, and protein C in plasma did not differ between patients with sepsis due to gram-negative and gram-positive bacteria. However, plasma IL-1beta, IL-6, and IL-18 concentrations were significantly higher in patients with sepsis due to gram-positive bacteria. Ex vivo stimulation of whole blood with heat-killed S. aureus markedly increased IL-1beta and IL-18 levels more than E. coli lipopolysaccharide stimulation. Microarray analysis revealed at least 359 cross-validated probe sets (genes) significant at the P < 0.001 level whose expression discriminated among gram-negative-organism-stimulated, gram-positive-organism-stimulated, and unstimulated whole-blood leukocytes. The host inflammatory responses to gram-negative and gram-positive stimuli share some common response elements but also exhibit distinct patterns of cytokine appearance and leukocyte gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500502      PMCID: PMC201043          DOI: 10.1128/IAI.71.10.5803-5813.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Why immunomodulatory therapies have not worked in sepsis.

Authors:  E Abraham
Journal:  Intensive Care Med       Date:  1999-06       Impact factor: 17.440

Review 2.  Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

Authors:  S M Opal; J Cohen
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

3.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

4.  Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock.

Authors:  C L Tannahill; K Fukuzuka; T Marum; Z Abouhamze; S L MacKay; E M Copeland; L L Moldawer
Journal:  Surgery       Date:  1999-08       Impact factor: 3.982

5.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

6.  Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model.

Authors:  J E Wang; P F Jørgensen; M Almlöf; C Thiemermann; S J Foster; A O Aasen; R Solberg
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin.

Authors:  Z M Wang; C Liu; R Dziarski
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

Review 8.  Sepsis syndrome.

Authors:  D E Fry
Journal:  Am Surg       Date:  2000-02       Impact factor: 0.688

9.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.

Authors:  D Novick; S H Kim; G Fantuzzi; L L Reznikov; C A Dinarello; M Rubinstein
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

Review 10.  Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target?

Authors:  A Oberholzer; C Oberholzer; R M Minter; L L Moldawer
Journal:  Immunol Lett       Date:  2001-01-15       Impact factor: 3.685

View more
  75 in total

1.  Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro.

Authors:  Yue Huang; Dejan Nikolic; Susan Pendland; Brian J Doyle; Tracie D Locklear; Gail B Mahady
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

2.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

3.  Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology.

Authors:  William O Hahn; Carmen Mikacenic; Brenda L Price; Susanna Harju-Baker; Ronit Katz; Jonathan Himmelfarb; Mark M Wurfel; W Conrad Liles
Journal:  Virulence       Date:  2016-01-28       Impact factor: 5.882

4.  Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis.

Authors:  Erin E Perrone; Enjae Jung; Elise Breed; Jessica A Dominguez; Zhe Liang; Andrew T Clark; W Michael Dunne; Eileen M Burd; Craig M Coopersmith
Journal:  Shock       Date:  2012-07       Impact factor: 3.454

5.  Porphyromonas gingivalis infection-induced tissue and bone transcriptional profiles.

Authors:  A Meka; V Bakthavatchalu; S Sathishkumar; M C Lopez; R K Verma; S M Wallet; I Bhattacharyya; B F Boyce; M Handfield; R J Lamont; H V Baker; J L Ebersole; L Kesavalu
Journal:  Mol Oral Microbiol       Date:  2010-02       Impact factor: 3.563

Review 6.  Biomarker discovery and development in pediatric critical care medicine.

Authors:  Jennifer M Kaplan; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

Review 7.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 8.  RNA profiling in host-pathogen interactions.

Authors:  Simon J Waddell; Philip D Butcher; Neil G Stoker
Journal:  Curr Opin Microbiol       Date:  2007-06-15       Impact factor: 7.934

9.  Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis.

Authors:  Amy C Fox; Charles M Robertson; Brian Belt; Andrew T Clark; Katherine C Chang; Ann M Leathersich; Jessica A Dominguez; Erin E Perrone; W Michael Dunne; Richard S Hotchkiss; Timothy G Buchman; David C Linehan; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

10.  Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses.

Authors:  Kevin W McConnell; Jonathan E McDunn; Andrew T Clark; W Michael Dunne; David J Dixon; Isaiah R Turnbull; Peter J Dipasco; William F Osberghaus; Benjamin Sherman; James R Martin; Michael J Walter; J Perren Cobb; Timothy G Buchman; Richard S Hotchkiss; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.